Author

Holly McAleese

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Observed institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

ORCID: 0000-0001-8444-8790

Observed ORCID: 0000-0001-8444-8790

OpenAlex ID: A5011579388

Structure-based design of a strain transcending AMA1-RON2L malaria vaccine

2023 · Palak N. Patel, Thayne H. Dickey, et al. · Nature Communications · 28

Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine

2023 · Thayne H. Dickey, Richi Gupta, et al. · npj Vaccines · 21

Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines

2023 · Thayne H. Dickey, Rui Ma, et al. · Cell Reports · 19

A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle

2023 · Nichole D. Salinas, Rui Ma, et al. · npj Vaccines · 17

A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity

2024 · Nichole D. Salinas, Rui Ma, et al. · Vaccines · 10

Structure‐based design of a Plasmodium vivax Duffy‐binding protein immunogen focuses the antibody response to functional epitopes

2024 · Thayne H. Dickey, Holly McAleese, et al. · Protein Science · 3

RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination

2024 · Thayne H. Dickey, Nichole D. Salinas, et al. · Antiviral Research

Works count: 7

Citation count: 98

H-index: 5

I10-index: 5